| | Title | Author(s) | Year | View Count | | 1 |  | Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma | Hui, MKC; Lai, KKY; Chan, KW; Luk, JM; Lee, NP; Chung, Y; Cheung, LC; Srivastava, G; Tsao, SW; Tang, JC; Law, S | 2012 | 91 |
| 2 |  | Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers | Cao, DX; Li, ZJ; Jiang, XO; Lum, YL; Khin, E; Lee, NPY; Wu, GH; Luk, JMC | 2012 | 24 |
| 3 | | Regulators of mammalian Hippo pathway in cancer | Liu, AM; Wong, KF; Jiang, X; Qiao, Y; Luk, JM | 2012 | 55 |
| 4 | | A morpho-molecular prognostic model for hepatocellular carcinoma | Srivastava, S; Wong, KF; Ong, CW; Huak, CY; Yeoh, KG; Teh, M; Luk, JM; SaltoTellez, M | 2012 | 33 |
| 5 | | Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study | Liu, AM; Yao, TJ; Wang, W; Wong, KF; Lee, NP; Fan, ST; Poon, RTP; Gao, C; Luk, JM | 2012 | 98 |
| 6 | | Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma | Sung, WK; Zheng, H; Li, S; Chen, R; Liu, X; Li, Y; Lee, NP; Lee, WH; Ariyaratne, PN; Tennakoon, C; Mulawadi, FH; Wong, KF; Liu, AM; Poon, RT; Fan, ST; Chan, KL; Gong, Z; Hu, Y; Lin, Z; Wang, G; Zhang, Q; Barber, TD; Chou, WC; Aggarwal, A; Hao, K; Zhou, W; Zhang, C; Hardwick, J; Buser, C; Xu, J; Kan, Z; Dai, H; Mao, M; Reinhard, C; Wang, J; Luk, JM | 2012 | 129 |
| 7 | | Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma | Fatima, S; Lee, NP; Tsang, FH; Kolligs, FT; Ng, IOL; Poon, RTP; Fan, ST; Luk, JM | 2012 | 135 |
| 8 | | Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents | Wong, KF; Yuan, Y; Luk, JM | 2012 | 55 |
| 9 | | Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer | Xu, Z; Zhu, H; Luk, JM; Wu, D; Gu, D; Gong, W; Tan, Y; Zhou, J; Tang, J; Zhang, Z; Wang, M; Chen, J | 2012 | 88 |
| 10 | | An update on targeting Hippo-YAP signaling in liver cancer | Liu, AM; Xu, Z; Luk, JM | 2012 | 70 |
| 11 |  | Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma | Hui, MKC; Lai, KKY; Chan, KW; Luk, JM; Lee, NP; Chung, Y; Cheung, LCM; Srivastava, G; Tsao, SW; Tang, JC; Law, S | 2012 | 121 |
| 12 | | Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma | Tung, EKK; Mak, CKM; Fatima, S; Lo, RCL; Zhao, H; Zhang, C; Dai, H; Poon, RTP; Yuen, MF; Lai, CL; Li, JJ; Luk, JMC; Ng, IOL | 2011 | 217 |
| 13 | | Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122 | Boutz, DR; Collins, PJ; Suresh, U; Lu, M; Ramírez, CM; FernándezHernando, C; Huang, Y; Abreu, RDS; Le, SY; Shapiro, BA; Liu, AM; Luk, JM; Aldred, SF; Trinklein, ND; Marcotte, EM; Penalva, LOF | 2011 | 161 |
| 14 | | Proteomics of hepatocellular carcinoma in chinese patients | Luk, JM; Liu, AM | 2011 | 117 |
| 15 | | Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma | Ivanovska, I; Zhang, C; Liu, AM; Wong, KF; Lee, NP; Lewis, P; Philippar, U; Bansal, D; Buser, C; Scott, M; Mao, M; Poon, RTP; Fan, ST; Cleary, MA; Luk, JM; Dai, H | 2011 | 96 |
| 16 | | Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy | Lu, WJ; Lee, NP; Kaul, SC; Lan, F; Poon, RTP; Wadhwa, R; Luk, JM | 2011 | 337 |
| 17 | | Dickkopfs and Wnt/β-catenin signalling in liver cancer | Fatima, S; Lee, NPY; Luk, JMC | 2011 | 101 |
| 18 | | Cytoplasmic Forkhead Box M1 (FoxM1) in Esophageal Squamous Cell Carcinoma Significantly Correlates with Pathological Disease Stage | Hui, MKC; Chan, KW; Luk, JM; Lee, NP; Chung, Y; Cheung, LCM; Srivastava, G; Tsao, SW; Tang, JC; Law, S | 2011 | 133 |
| 19 | | Clinicopathologic and gene expression parameters predict liver cancer prognosis | Hao, K; Lamb, J; Zhang, C; Xie, T; Wang, K; Zhang, B; Chudin, E; Lee, NP; Mao, M; Zhong, H; Greenawalt, D; Ferguson, MD; Ng, IO; Sham, PC; Poon, RT; Molony, C; Schadt, EE; Dai, H; Luk, JM | 2011 | 112 |
| 20 | | AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma | Xu, MZ; Chan, SW; Liu, AM; Wong, KF; Fan, ST; Chen, J; Poon, RT; Zender, L; Lowe, SW; Hong, W; Luk, JM | 2011 | 427 |
|
